Taipei Exchange - Delayed Quote TWD

Greenyn Biotechnology Co., Ltd (6846.TWO)

Compare
79.70
-0.10
(-0.13%)
At close: January 22 at 1:30:40 PM GMT+8

Key Executives

Greenyn Biotechnology Co., Ltd

No. 43, Keya Road
5th Floor Daya District
Taichung, 428
Taiwan
886 4 2238 2860 https://www.greenynbio.com
Sector: 
Healthcare
Industry: 
Biotechnology

Description

Greenyn Biotechnology Co., Ltd, a dietary supplement company, develops, manufactures, and sells health products in Taiwan and internationally. The company offers proprietary ingredients, such as Insumate, a bitter melon extract; Antromax, an antrodia cinnamomea; and Zymologist 101 Phyto fermented drink. It also provides functional formulas for youth and beauty series, digestive health series, brain health series, body regulation series, throat moistening series, hair care series, clear eye series, colorful lifestyle series, joint health series, nutritional supplement series, energy supplement series, immune modulation series, low burden series, sleep aid series, body curve series, circulation series, man power series, women's intimate health series, and mature woman series. In addition, the company offers customization, ODM, dosage, and application services. Greenyn Biotechnology Co., Ltd was founded in 2012 and is based in Taichung, Taiwan.

Corporate Governance

Greenyn Biotechnology Co., Ltd’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

March 30, 2023 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers